Abstract: This disclosure above describes a method, a device, and a system for encrypting/decrypting physical channels in a wireless communication network. Among various embodiments are: pre-allocating a key, dynamically granting a key, encrypting the physical channel based on key in various levels, dividing the spectrum into two categories, or dividing a network into an initial access network and a private network. In one embodiment, a method for physical channel encryption is disclosed. Performed by a UE, the method may include obtaining a first key for decrypting a first physical channel, the first physical channel being encrypted; and decrypting the first physical channel based on the first key to obtain a signal or data transmitted by a first network element, the signal or the data being carried in the first physical channel.

Abstract: A vehicle seat assembly installed in a cabin of a vehicle having a vehicle seat and a side airbag device; the vehicle seat having a seat back and a seat base; the seat back connected to the seat base in a manner movable relative to the seat base in the front-rear direction of the vehicle. The side airbag device arranged on the vehicle seat including: a first side airbag and a second side airbag not in fluid communication with each other and configured to be unfolded between the vehicle seat and the side wall of the vehicle when in an inflated state; a controller for determining the orientation of the vehicle seat and detecting an impact signal to output a control signal; and a gas generator for generating gas on the basis of the control signal of the controller to inflate the first side airbag or second side airbag.

Abstract: Systems and methods for simulating a circuit board design include receiving a printed circuit board design comprising an electronic component and a dielectric board, generating a first finite element model of the dielectric board independent of the electronic component, and generating a second finite element model for the electronic component. The method further includes combining the first finite element model with the second finite element model to obtain a final finite element model for the printed circuit board design.

Abstract: Provided is engineered microorganisms expressing acetoacetyl-CoA reductase variants and a method for improving the yield of PHA. Compared with the wild-type acetoacetyl-CoA reductase represented by SEQ ID NO. 31, the variant has one or more of the following mutations: (1) mutation of valine at position 141 to isoleucine or leucine; (2) mutation of methionine at position 12 to threonine, serine, alanine, leucine, lysine or isoleucine; (3) mutation of isoleucine at position 194 to valine, leucine or methionine; (4) mutation of glutamic acid at position 42 to lysine, glutamine, leucine, aspartic acid, proline, threonine, asparagine, or histidine; and (5) mutation of phenylalanine at position 55 to valine, alanine or isoleucine. The variants and their coding genes can promote the synthesis and accumulation of PHA by the strain and increase the yield of PHA.

Abstract: A coated cathode material includes a cathode active material and an interfacial layer coating the cathode active material. The interfacial layer includes a lithium-containing fluoride which includes at least one additional metal different from lithium.

Abstract: A memory data migration method, apparatus, and system are provided. During memory migration, data is classified into two parts based on a hot and cold degree of the data. Hot data is directly migrated, and cold data is written into a shared storage device shared by memories. When needing to be used in a destination-end memory, the cold data may be read from the shared storage device. This reduces an amount of data that needs to be migrated to the destination-end memory, thereby improving memory migration efficiency.

Abstract: Disclosed are particles comprising lithium salts and methods for their use in treating inflammatory conditions.

Abstract: A connector is provided including a housing and a terminal set. The housing is a conductor and has a connection end and a fixed end. The terminal set includes a plurality of signal terminals and a plurality of grounding terminals. The plurality of grounding terminals includes at least a first grounding terminal. A length of the first grounding terminal is less than 50% of a length of the longest signal terminal, and the first grounding terminal is directly or indirectly electrically connected to a grounding surface to achieve grounding. The grounding terminal is greatly shortened and is not required to pass through the fixed end to be connected to a printed circuit board (PCB), which greatly alleviates the problem of resonance caused by an excessive length of the grounding terminal and improves quality of signal transmission.

Abstract: A high-frequency signal switching apparatus and a testing apparatus are provided. The switching apparatus comprises at least one switching module comprising a first input port; a second input port; a plurality of output ports; a primary-stage switching element group comprising at least a first primary-stage switch and a second primary-stage switch, and a final-stage switching element group comprising a plurality of final-stage switches; wherein a head-end interface of the first primary-stage switch is electrically connected to the first input port, a head-end interface of the second primary-stage switch is electrically connected to the second input port; and each final-stage switch is optionally electrically connected to the first primary-stage switch, the second primary-stage switch, and two of the plurality of output ports simultaneously, thereby the two output ports being respectively and optionally electrically connected to the first input port and the second input port.

Abstract: A memory data migration method, apparatus, and system are provided. During memory migration, data is classified into two parts based on a hot and cold degree of the data. Hot data is directly migrated, and cold data is written into a shared storage device shared by memories. When needing to be used in a destination-end memory, the cold data may be read from the shared storage device. This reduces an amount of data that needs to be migrated to the destination-end memory, thereby improving memory migration efficiency.

Abstract: Radiosensitizer prodrugs and formulations and methods of use thereof are provided. Typically, the radiosensitizer prodrug is an analog of a radiosensitizer parent compound having one or more S-nitrosothiol moieties. Typically, the S—N bond of the S-nitrosothiol moiety can be cleaved by radiation during radiotherapy, releasing the parent compound and nitric oxide. One or preferably both the parent compound and the nitric oxide can contribute to death of tumor cells exposed to radiotherapy. Nanoparticle formulations for delivery of the prodrug, and methods of using them in combination with radiotherapy to treat tumors and cancer are also provided.

Abstract: An anode includes: (1) a current collector; and (2) an interfacial layer disposed over the current collector. The interfacial layer includes a film of a layered material and a reinforcing material selectively disposed over certain regions of the film, while other regions of the film remain exposed from the reinforcing material.

Abstract: A memory data migration method, apparatus, and system are provided. During memory migration, data is classified into two parts based on a hot and cold degree of the data. Hot data is directly migrated, and cold data is written into a shared storage device shared by memories. When needing to be used in a destination-end memory, the cold data may be read from the shared storage device. This reduces an amount of data that needs to be migrated to the destination-end memory, thereby improving memory migration efficiency.

Abstract: The present invention describes a system and method for selecting and optimizing a sound stimulus using a deep neural network to regulate and improve human sleep quality. The deep neural network has the capability of characterizing processing of human brain cortical neurons for external stimulus (images, sounds, etc.) information. By inputting massive sound stimuli into the deep neural network, a sound mode which causes model-estimated sleep electroencephalograph to be optimal can be found, the sound mode is applied to a real human body, and the intensity of corresponding sleep waves of the human body in different sleep stages is enhanced through closed-loop optimization so as to realize the purpose of regulating sleep. The present invention mainly aims at solving the technical problem of how to select and optimize, when a sound stimulus means (music, speech, natural sounds, white/colored noise, etc.) is used to assist in human sleep.

Abstract: Particles formed from an alkai metal or alkaline earth metal and halide, for example, sodium and chloride, are provided. The particles can have a hydrophilic coating or external layer, formed of, for example, a polyether-lipid conjugate. In preferred embodiments, the lipid is a phospholipid such as a phosphoethanolamine, and the polyether is a polyethylene glycol such as a PEG amine. Methods making the particles by, for example, a microemulsion reaction, are also provided. Pharmaceutical compositions including a plurality of particles and a pharmaceutically acceptable carrier are also disclosed. Typically the compositions include an effective amount of particles to treat a disease or condition, particularly cancer, in a subject in need thereof. The particles are typically nanoparticles, for example, between about 10 nm and 250 nm and can be monodisperse.

Abstract: Disclosed herein are nanoparticles comprising a therapeutic or diagnostic agent positioned within an orthosilicate inner matrix, and a silica outer shell encapsulating the orthosilicate inner matrix. Also disclosed are methods of treating a disease in a subject comprising administering to the subject a biological carrier cell comprising the nanoparticle. Also disclosed are methods of preparing nanoparticles, methods of delivering nanoparticles comprising a therapeutic or diagnostic agent to a target cell, and methods of loading a therapeutic or diagnostic agent into a biological carrier cell.